STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - NYSE:STVN - IT0005452658 - Common Stock
24.06 USD
-0.47 (-1.92%)
24.06 USD
0 (0%)
STVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 56 industry peers in the Life Sciences Tools & Services industry. While STVN has a great profitability rating, there are some minor concerns on its financial health. STVN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year STVN was profitable.
STVN had a positive operating cash flow in the past year.
STVN had positive earnings in each of the past 5 years.
STVN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 5.72%, STVN belongs to the best of the industry, outperforming 80.36% of the companies in the same industry.
STVN has a better Return On Equity (9.63%) than 78.57% of its industry peers.
STVN's Return On Invested Capital of 7.90% is fine compared to the rest of the industry. STVN outperforms 78.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for STVN is significantly below the industry average of 14.93%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROIC | 7.9% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
STVN has a Profit Margin of 11.75%. This is in the better half of the industry: STVN outperforms 78.57% of its industry peers.
In the last couple of years the Profit Margin of STVN has grown nicely.
STVN has a Operating Margin of 17.17%. This is amongst the best in the industry. STVN outperforms 80.36% of its industry peers.
In the last couple of years the Operating Margin of STVN has grown nicely.
STVN has a worse Gross Margin (28.83%) than 75.00% of its industry peers.
STVN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), STVN is creating some value.
The number of shares outstanding for STVN has been increased compared to 1 year ago.
STVN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for STVN has been reduced compared to a year ago.
2.2 Solvency
STVN has an Altman-Z score of 5.32. This indicates that STVN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.32, STVN belongs to the best of the industry, outperforming 80.36% of the companies in the same industry.
STVN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
STVN has a Debt to Equity ratio of 0.24. This is comparable to the rest of the industry: STVN outperforms 53.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.32 |
ROIC/WACC0.94
WACC8.37%
2.3 Liquidity
A Current Ratio of 1.79 indicates that STVN should not have too much problems paying its short term obligations.
STVN's Current ratio of 1.79 is on the low side compared to the rest of the industry. STVN is outperformed by 60.71% of its industry peers.
STVN has a Quick Ratio of 1.22. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
STVN has a Quick ratio of 1.22. This is in the lower half of the industry: STVN underperforms 76.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.00% over the past year.
Measured over the past years, STVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.29% on average per year.
Looking at the last year, STVN shows a small growth in Revenue. The Revenue has grown by 5.28% in the last year.
STVN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.53% yearly.
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
3.2 Future
The Earnings Per Share is expected to grow by 17.54% on average over the next years. This is quite good.
Based on estimates for the next years, STVN will show a small growth in Revenue. The Revenue will grow by 7.87% on average per year.
EPS Next Y11.52%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
EPS Next 5Y17.54%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.87%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 39.44, which means the current valuation is very expensive for STVN.
Based on the Price/Earnings ratio, STVN is valued a bit cheaper than 60.71% of the companies in the same industry.
STVN is valuated rather expensively when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 31.09 indicates a quite expensive valuation of STVN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STVN indicates a somewhat cheap valuation: STVN is cheaper than 66.07% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of STVN to the average of the S&P500 Index (23.21), we can say STVN is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.44 | ||
| Fwd PE | 31.09 |
4.2 Price Multiples
75.00% of the companies in the same industry are more expensive than STVN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates STVN does not grow enough to justify the current Price/Earnings ratio.
STVN has a very decent profitability rating, which may justify a higher PE ratio.
STVN's earnings are expected to grow with 19.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.42
PEG (5Y)1.45
EPS Next 2Y17.57%
EPS Next 3Y19.74%
5. Dividend
5.1 Amount
With a yearly dividend of 0.23%, STVN is not a good candidate for dividend investing.
STVN's Dividend Yield is rather good when compared to the industry average which is at 0.51. STVN pays more dividend than 82.14% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, STVN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
5.2 History
STVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
10.74% of the earnings are spent on dividend by STVN. This is a low number and sustainable payout ratio.
DP10.74%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
24.06
-0.47 (-1.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners111.37%
Inst Owner Change0%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap6.57B
Analysts83.53
Price Target29.69 (23.4%)
Short Float %4.34%
Short Ratio5.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.74%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)6.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.03%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-0.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.44 | ||
| Fwd PE | 31.09 | ||
| P/S | 4.92 | ||
| P/FCF | N/A | ||
| P/OCF | 27.25 | ||
| P/B | 4.03 | ||
| P/tB | 4.28 | ||
| EV/EBITDA | 21.52 |
EPS(TTM)0.61
EY2.54%
EPS(NY)0.77
Fwd EY3.22%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.88
OCFY3.67%
SpS4.9
BVpS5.98
TBVpS5.62
PEG (NY)3.42
PEG (5Y)1.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROCE | 10.51% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.32% | ||
| ROICexgc | 8.73% | ||
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexcg growth 3Y-28.59%
ROICexcg growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.83 | ||
| Cash Conversion | 74.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.32 |
F-Score5
WACC8.37%
ROIC/WACC0.94
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
EPS Next Y11.52%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
EPS Next 5Y17.54%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.87%
EBIT growth 1Y6.16%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year71.18%
EBIT Next 3Y33.24%
EBIT Next 5Y23.69%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%